Buy Methylone (Bk-MDMA)
Buy Methylone (Bk-MDMA). Methylone (BK-MDMA) is a synthetic stimulant and entactogen with effects similar to MDMA and amphetamines. People often use it recreationally for its euphoric and empathogenic effects. It typically appears as a white or off-white powder or crystal.
Effects:
– Euphoria: Users feel intense happiness, emotional warmth, and heightened mood.
– Empathy: It enhances feelings of connection and sociability.
– Stimulation: It boosts energy, alertness, and physical activity.
– Sensory Enhancement: Colors, sounds, and touch may feel more intense.
Risks:
– Overdose: High doses can cause severe anxiety, paranoia, and hallucinations.
– Cardiovascular Strain: It increases heart rate and blood pressure, risking heart issues.
– Serotonin Depletion: Overuse may lead to mood crashes, depression, and fatigue.
– Dehydration and Overheating: It can cause hyperthermia and dehydration, especially in hot environments.
– Unknown Long-Term Effects: Limited research makes its long-term health risks unclear.
Harm Reduction Tips:
– Test Your Drugs: Use reagent test kits to check for purity and avoid harmful adulterants.
– Start Low: Begin with a small dose to gauge effects and reduce risks.
– Stay Hydrated: Drink water in moderation to prevent dehydration or overhydration.
– Take Breaks: Rest in cool areas to avoid overheating.
– Avoid Mixing: Do not combine methylone with alcohol.
Methylone offers short-term euphoria and energy but carries significant risks, including overdose and serotonin depletion. Always prioritize safety and consider the potential harm to your health.
| Weight | 10g, 50g, 100g, 500g |
|---|
Be the first to review “Methylone (Bk-MDMA)”
Related products
Psychedelics
(4-Bromo-2,5-dimethoxyphenethylamine) is a psychedelic drug first synthesized in 1974 by Dr. George Shulgin.
Psychedelics
5,6-Methylenedioxy-2-aminoindane (commonly known as MDAI) is an entactogen substance of the aminoindane chemical class that produces entactogenic effects when administered.Notably, this compound primarily produces the non-stimulating effects of prototypical entactogens like MDMA such as sedation, muscle relaxation, and tactile enhancement. 5,6-methylenedioxy-2-aminoindane, was developed in the 1990s by a team led by David E. Nichols at Purdue University. It acts as a putatively non-neurotoxic and highly selective serotonin releasing agent (SSRA) with neglible effects on dopamine and norepinephrine. This reportedly limits its potential at producing overtly invigorating, prosocial or euphoric effects. 5,6-methylenedioxy-2-aminoindane,has been marketed alongside research chemical entactogens like 5-MAPB, 5-APB, and 6-APB as a legal, grey-market alternative to MDMA. Very little data exists about the pharmacological properties, metabolism, and toxicity of 5,6-methylenedioxy-2-aminoindane,, and it has a limited history of human use. It is highly advised to use harm reduction practices if using this substance.
Reviews
There are no reviews yet.